Increased Prevalence of Vestibular Loss in Mild Cognitive Impairment and Alzheimer's Disease

被引:27
|
作者
Wei, Eric X. [1 ]
Oh, Esther S. [2 ]
Harun, Aisha [1 ]
Ehrenburg, Matthew [1 ]
Xue, Qian-Li [3 ]
Simonsick, Eleanor [4 ]
Agrawal, Yuri [1 ]
机构
[1] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, 601 N Caroline St, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Dept Med, Sch Med, 5200 Eastern Ave,Seventh Floor, Baltimore, MD 21224 USA
[3] Johns Hopkins Univ, Dept Med, Div Geriatr Med & Gerontol, Sch Med, 2024 E Monument St,Suite 2-722, Baltimore, MD 21205 USA
[4] NIA, NIH, 3001 S Hanover St,5th Floor, Baltimore, MD 21225 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; mild cognitive impairment; vestibular system; vestibular function tests; aging; HEAD IMPULSE TEST; EVOKED MYOGENIC POTENTIALS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; HIPPOCAMPAL; DEMENTIA; STIMULATION; RECOMMENDATIONS; DYSFUNCTION;
D O I
10.2174/1567205016666190816114838
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background/Aims: Recent evidence has shown that Alzheimer's Disease (AD) patients have reduced vestibular function relative to healthy controls. In this study, we evaluated whether patients with Mild Cognitive Impairment (MCI) also have reduced vestibular function relative to controls, and compared the level of vestibular impairment between MCI and AD patients. Methods: Vestibular physiologic function was assessed in 77 patients (26 MCI, 51 AD) and 295 matched controls using 3 clinical vestibular tests. The association between vestibular loss and cognitive impairment was evaluated using conditional logistic regression models. Results: Individuals with vestibular impairment had a 3 to 4-fold increased odds of being in the MCI vs. control group (p-values < 0.05). MCI patients had a level of vestibular impairment that was intermediate between controls and AD. Conclusion: These findings suggest a dose-response relationship between vestibular loss and cognitive status, and support the hypothesis that vestibular loss contributes to cognitive decline.
引用
收藏
页码:1143 / 1150
页数:8
相关论文
共 50 条
  • [41] Transcriptomic predictors of rapid progression from mild cognitive impairment to Alzheimer's disease
    Huang, Yi-Long
    Tsai, Tsung-Hsien
    Shen, Zhao-Qing
    Chan, Yun-Hsuan
    Tu, Chih-Wei
    Tung, Chien-Yi
    Wang, Pei-Ning
    Tsai, Ting-Fen
    ALZHEIMERS RESEARCH & THERAPY, 2025, 17 (01)
  • [42] Dynamic balance deficit and the neural network in Alzheimer's disease and mild cognitive impairment
    Ide, Ryotaro
    Ota, Miho
    Hada, Yasushi
    Watanabe, Serina
    Takahashi, Takumi
    Tamura, Masashi
    Nemoto, Kiyotaka
    Arai, Tetsuaki
    GAIT & POSTURE, 2022, 93 : 252 - 258
  • [43] White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease
    Misquitta, Karen
    Dadar, Mahsa
    Collins, D. Louis
    Tartaglia, Maria Carmela
    NEUROIMAGE-CLINICAL, 2020, 28
  • [44] Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases
    Hessen, Erik
    Stav, Ane Lovli
    Auning, Eirik
    Selnes, Per
    Blomso, Linn
    Holmeide, Cathrine Emilie
    Johansen, Krisztina Kunszt
    Eliassen, Carl Fredrik
    Reinvang, Ivar
    Fladby, Tormod
    Aarsland, Dag
    JOURNAL OF PARKINSONS DISEASE, 2016, 6 (02) : 413 - 421
  • [45] Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
    Kivisakk, Pia
    Carlyle, Becky C.
    Sweeney, Thadryan
    Trombetta, Bianca A.
    LaCasse, Kathryn
    El-Mufti, Leena
    Tuncali, Idil
    Chibnik, Lori B.
    Das, Sudeshna
    Scherzer, Clemens R.
    Johnson, Keith A.
    Dickerson, Bradford C.
    Gomez-Isla, Teresa
    Blacker, Deborah
    Oakley, Derek H.
    Frosch, Matthew P.
    Hyman, Bradley T.
    Aghvanyan, Anahit
    Bathala, Pradeepthi
    Campbell, Christopher
    Sigal, George
    Stengelin, Martin
    Arnold, Steven E.
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [46] Prevalence of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease, and its Relationship with Cognitive Impairment
    Fernandez-Martinez, M.
    Molano, A.
    Castro, J.
    Zarranz, J. J.
    CURRENT ALZHEIMER RESEARCH, 2010, 7 (06) : 517 - 526
  • [47] Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging
    Brueggen, Katharina
    Dyrba, Martin
    Cardenas-Blanco, Arturo
    Schneider, Anja
    Fliessbach, Klaus
    Buerger, Katharina
    Janowitz, Daniel
    Peters, Oliver
    Menne, Felix
    Priller, Josef
    Spruth, Eike
    Wiltfang, Jens
    Vukovich, Ruth
    Laske, Christoph
    Buchmann, Martina
    Wagner, Michael
    Roeske, Sandra
    Spottke, Annika
    Rudolph, Janna
    Metzger, Coraline D.
    Kilimann, Ingo
    Dobisch, Laura
    Dueze, Emrah
    Jessen, Frank
    Teipel, Stefan J.
    JOURNAL OF NEUROLOGY, 2019, 266 (10) : 2465 - 2474
  • [48] When Alzheimer's disease actually begins - the new criteria for mild cognitive impairment and Alzheimer's disease
    Bartos, Ales
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2012, 75 (01) : 108 - 109
  • [49] Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study
    Scaricamazza, Eugenia
    Colonna, Isabella
    Sancesario, Giulia Maria
    Assogna, Francesca
    Orfei, Maria Donata
    Franchini, Flaminia
    Sancesario, Giuseppe
    Mercuri, Nicola Biagio
    Liguori, Claudio
    NEUROLOGICAL SCIENCES, 2019, 40 (07) : 1377 - 1382
  • [50] Prospective predictors of decline v. stability in mild cognitive impairment with Lewy bodies or Alzheimer's disease
    Hamilton, Calum A.
    Matthews, Fiona E.
    Donaghy, Paul C.
    Taylor, John-Paul
    O'Brien, John T.
    Barnett, Nicola
    Olsen, Kirsty
    McKeith, Ian G.
    Thomas, Alan J.
    PSYCHOLOGICAL MEDICINE, 2021, 51 (15) : 2590 - 2598